All posts
14550 total · page 28 of 291

Molbio Diagnostics Targets ₹940 Crore in IPO for Global Expansion
Molbio Diagnostics seeks ₹940 crore in IPO to fund growth, with focus on tuberculosis kits and international markets.

Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests a 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE transactions.

Surrogate Battles for Custody After Birth Amid Parental Dispute
A surrogate gave birth in Texas amid a legal fight with the biological parents over a request to terminate the pregnancy.

Trump's Vaccine Cut Sparks Parental Concerns Amid Autism Claims
Trump reduces recommended vaccines for children citing autism, despite studies showing no link.

Medical Device Industry Criticizes Draft Bill: Calls for Regulatory Distinction
India's medical device sector opposes the Draft Bill 2026, arguing it wrongly equates devices with pharmaceuticals, risking innovation and investment.

Abhay Soi Challenges Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against room rent caps, citing investment needs.

Molbio Diagnostics Sets Sights on ₹940 Crore IPO Amid Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO, aiming to enhance capital expenditures and reduce promoter stake, as it targets global growth.

Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare for Rs 986 crore, reducing its stake to 51.02%.

Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate birth in Texas escalates into a legal fight as the surrogate seeks custody after fleeing amid a medical dispute.

Medical Device Industry Opposes India's Draft Bill on Regulatory Grounds
India’s medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.

Abhay Soi Challenges Hospital Price Cap Amid Investment Concerns
Max Healthcare's Abhay Soi argues against a blanket price cap on hospital rooms, highlighting investment needs.

NABL Unveils India's First Mobile Food Testing Accreditation
NABL has introduced India's inaugural mobile food testing accreditation, enhancing food safety compliance.

India Approves 1,500 New CDSCO Positions to Bolster Medical Device Oversight
India's government has approved 1,500 new positions within the CDSCO to enhance regulation of medical devices across the country.

CDSCO Sets Guidelines for AI, Software Medical Device Regulation
India's CDSCO releases new guidelines for regulating AI and software-based medical devices.

Molbio Diagnostics Eyes ₹940 Crore Through IPO for Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO to fund capital projects and reduce promoter stake, targeting long-term growth.

Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of its stake in Thyrocare, raising Rs 986 crore through bulk and block deals on NSE and BSE.

Cab and Auto Drivers Account for 30% of Sudden Cardiac Arrest Deaths in Karnataka District
A study reveals that cab and auto drivers in a Karnataka district face higher risks of sudden cardiac arrest due to lifestyle and work conditions.

Combatting Sarcopenia: Strategies for Muscle Preservation in Your 40s
Muscle loss can begin in your 40s, but targeted exercises, nutrition, and lifestyle changes can help combat sarcopenia effectively.

Surrogate Birth Sparks Legal Battle Over Child's Custody
A surrogate fled to Texas to give birth amid a dispute with biological parents over a severe heart defect diagnosis.

Industry Pushback: Medical Devices Oppose India's 2026 Draft Bill
India's medical device industry challenges a draft bill equating devices with pharmaceuticals, citing potential harm to innovation and investment.

Abhay Soi Challenges Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi questions the feasibility of capping hospital room rents amid investment needs.

Molbio Diagnostics Eyes ₹200 Crore from IPO Amid Global Expansion
Molbio Diagnostics seeks to raise ₹200 crore for expansion and reduce promoter stake via a ₹740 crore offer for sale.

Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare, reducing its stake to 51.02%. The Rs 986 crore deal involves major institutional investors.

Surrogate Birth Sparks Legal Battle Over Child's Custody
A surrogate who gave birth in Texas is entangled in a legal fight to regain custody after biological parents sought pregnancy termination.

Indian Medical Device Sector Pushes Back Against Draft Bill
India's medical device industry opposes a draft bill that equates devices with drugs, citing risks to innovation and investment.

Max Healthcare's Abhay Soi Challenges Proposed Hospital Room Price Cap
Abhay Soi of Max Healthcare argues against a blanket price cap on hospital rooms, citing investment viability concerns.

Yulu Secures $93 Million to Accelerate E-Bike Expansion in India
Yulu, the Indian e-bike rental startup, has raised $93 million to enhance its fleet and expand operations across the country.

Kalshi Eyes $750M Investment from Sequoia, Wellington
Kalshi seeks $750 million in funding, potentially valuing the platform at $40 billion.

Punjab & Sind Bank Considers QIP to Reduce Govt Stake
Punjab & Sind Bank is evaluating a Qualified Institutional Placement to raise funds and decrease government ownership.

Australian Leader's India Visit Aims to Boost Trade, Investment
An Australian regional leader is set to visit India to enhance trade and investment ties.

Poland Introduces Tax-Free Accounts to Spur Domestic Investment
Poland launches tax-free personal accounts to enhance local investment and economic growth.

Tamil Nadu Secures ₹67,542 Crore in MoUs at Investment Conclave
Tamil Nadu's first investment conclave under the TVK government sees 97 MoUs signed, promising ₹67,542 crore in investments.

Molbio Diagnostics IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics plans to raise ₹940 crore via IPO, targeting capital expansion and stake reduction.

Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare for Rs 986 crore, reducing its stake to 51.02%.

AKKARE Investigates Aging Among Kerala Americans and Migration Effects
AKKARE explores how migration impacts aging by studying the Kerala American community.

Karnataka Sees Spike in Sudden Cardiac Arrests Among Cab, Auto Drivers
In a Karnataka district, 6 out of 20 sudden cardiac deaths were cab or auto drivers. Experts highlight key contributing factors.

Surrogate Birth Sparks Legal Battle After Parents' Termination Request
A surrogate gave birth in Texas amid a legal fight after biological parents requested pregnancy termination at 20 weeks.

Industry Pushback: Draft Bill Equates Medical Devices to Pharma
India's medical device sector opposes a draft bill equating devices to drugs, citing potential harm to innovation and investment.

Max Healthcare's Abhay Soi Critiques Proposed Hospital Room Price Cap
Abhay Soi warns a price cap on hospital rooms could hinder investment in new facilities.

Molbio Diagnostics IPO: A High-Risk, High-Reward Opportunity?
Molbio Diagnostics is set to raise ₹940 crore through its IPO, aiming to expand operations and reduce promoter stakes.

Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE deals.

Surrogate Birth Triggers Legal Battle Over Child's Custody
A surrogate gave birth in Texas amid a legal dispute after biological parents requested pregnancy termination.

Medical Device Industry Challenges India's Draft Regulatory Bill
India's medical device sector opposes a draft bill aligning it with pharma, citing risks to innovation and investment.

Abhay Soi Challenges Private Hospital Price Cap Proposal
Max Healthcare's Abhay Soi argues against a price cap on private hospital rooms, citing investment needs.

Molbio Diagnostics Eyes ₹940 Crore Through IPO for Expansion and Promoter Stake Sale
Molbio Diagnostics plans a ₹940 crore IPO to fund capital expansion and reduce promoter stake, targeting high-risk investors.

Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore through bulk and block deals.

AI to Alleviate Doctors' Paperwork Amid Looming Health Worker Shortage
AI can reduce doctors' admin tasks, addressing a projected 10 million health worker shortage by 2030.

Surrogate Birth Sparks Legal Battle Over Baby's Custody
A surrogate birth in Texas leads to a custody battle after parents requested a pregnancy termination due to a heart defect.

Medical Device Industry Challenges India's New Regulatory Draft
The draft Drugs, Medical Devices, and Cosmetics Bill, 2026 faces opposition for equating medical devices with pharmaceuticals.

Abhay Soi Criticizes Proposed Cap on Private Hospital Room Rates
Max Healthcare's Abhay Soi warns against a blanket price cap on hospital room rents, citing investment concerns.
